Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESMT
3101
DELISTED
EngageSmart, Inc.
ESMT
| $607K | ﹤0.01% |
34,506
-2,982
| -8% | -$54.7K |
|
3102
PUT
Freshpet
FRPT
$3.07B
| $607K | ﹤0.01% |
+11,500
| New | +$684K |
|
|
EVBN
3103
DELISTED
Evans Bancorp Inc
EVBN
| $606K | ﹤0.01% |
16,220
+2,259
| +16% | +$84.5K |
|
3104
Skillsoft
SKIL
$72.3M
| $606K | ﹤0.01% |
23,304
+19,979
| +601% | +$666K |
|
3105
SFL Corp
SFL
$1.61B
| $606K | ﹤0.01% |
65,715
+24,548
| +60% | +$239K |
|
3106
CALL
Teladoc Health
TDOC
$1.22B
| $605K | ﹤0.01% |
+25,600
| New | +$690K |
|
3107
XPEL
XPEL
$1.27B
| $604K | ﹤0.01% |
10,059
+4,896
| +95% | +$313K |
|
3108
CorMedix
CRMD
$590M
| $604K | ﹤0.01% |
143,132
| – | – |
|
|
RETA
3109
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $603K | ﹤0.01% |
15,870
+2,008
| +14% | +$69.1K |
|
3110
Telephone and Data Systems
TDS
$4.07B
| $603K | ﹤0.01% |
57,460
-3,772
| -6% | -$46.7K |
|
3111
CBIZ
CBZ
$2.99B
| $603K | ﹤0.01% |
12,864
+10,306
| +403% | +$490K |
|
3112
InvenTrust Properties
IVT
$2.66B
| $601K | ﹤0.01% |
25,404
+12,149
| +92% | +$290K |
|
|
TGAA
3113
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
| $601K | ﹤0.01% |
58,646
| – | – |
|
3114
Byline Bancorp
BY
$1.81B
| $599K | ﹤0.01% |
26,081
-4,249
| -14% | -$95.3K |
|
3115
Crawford & Co Class A
CRD.A
$610M
| $599K | ﹤0.01% |
107,699
+2,673
| +3% | +$16.3K |
|
3116
Tango Therapeutics
TNGX
$4.78B
| $598K | ﹤0.01% |
82,522
-37,193
| -31% | -$262K |
|
3117
Flywire
FLYW
$2.13B
| $596K | ﹤0.01% |
24,343
+21,945
| +915% | +$473K |
|
3118
Petco
WOOF
$845M
| $594K | ﹤0.01% |
62,637
+30,812
| +97% | +$316K |
|
3119
Asana
ASAN
$2.02B
| $593K | ﹤0.01% |
43,052
+10,266
| +31% | +$186K |
|
3120
Star Bulk Carriers
SBLK
$3.15B
| $590K | ﹤0.01% |
30,675
-18,621
| -38% | -$363K |
|
|
CIO
3121
DELISTED
City Office REIT
CIO
| $590K | ﹤0.01% |
70,351
+12,304
| +21% | +$118K |
|
|
AVTA
3122
DELISTED
Avantax, Inc. Common Stock
AVTA
| $589K | ﹤0.01% |
23,087
+7,049
| +44% | +$162K |
|
3123
Safety Insurance
SAFT
$1.52B
| $589K | ﹤0.01% |
6,991
+3,193
| +84% | +$271K |
|
3124
MoonLake Immunotherapeutics
MLTX
$1.53B
| $587K | ﹤0.01% |
55,952
+40,768
| +268% | +$363K |
|
3125
Coursera
COUR
$1.75B
| $586K | ﹤0.01% |
49,571
-11,580
| -19% | -$146K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.